Alpine Immune Sciences
Latest round
- Series A
Last raised
- Jun 2016
Total raised
- $11M
Investors
- 3
About Alpine Immune Sciences
, operates as a biopharmaceutical that provides development of immunotherapies for autoimmune and inflammatory diseases. The company is listed on the Nasdaq under the ticker symbol ALPN. In April 2024, Vertex Pharmaceuticals Incorporated agreed to acquire Alpine Immune Sciences, Inc.9 billion, or USD 65 per share. The transaction is expected to be completed this second quarter of 2024. The company's diverse pipeline includes programs like Povetacicept (ALPN-303), a dual B cell cytokine antagonist for systemic lupus erythematosus and glomerulonephritis. Alpine also has partnered programs such as Acazicolcept (ALPN-101), a dual CD28/ICOS antagonist in Phase 2 trials for systemic lupus erythematosus.
Who invested in Alpine Immune Sciences
3 investors across 2 rounds
See all investors in Alpine Immune Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alpine Immune Sciences
Who invested in Alpine Immune Sciences?
Alpine Immune Sciences has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alpine Immune Sciences raised?
Alpine Immune Sciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alpine Immune Sciences last raise money?
Alpine Immune Sciences's most recent round on record is a Series A, in Jun 2016.
What does Alpine Immune Sciences do?
, operates as a biopharmaceutical that provides development of immunotherapies for autoimmune and inflammatory diseases.
Where is Alpine Immune Sciences headquartered?
Alpine Immune Sciences is headquartered in Seattle, US.
Which VCs invest in companies like Alpine Immune Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alpine Immune Sciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Alpine Immune Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.